Triple-Negative Breast Cancer (TNBC) Recruiting Phase 1 / 2 Trials for Carboplatin (DB00958)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02993094Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast CancerTreatment